Infection Surveillance Solutions Market

Market Insights

The infection surveillance solutions market is set to reach US$ 934.7 Mn in 2026 from US$ 330.7 Mn in 2017, projecting excellent growth at a CAGR of 12.4% from 2018 to 2026. As per the latest research cited by the World Health Organization (WHO), in the near future, the looming threat of hospital-acquired infection and rampant growth in antibiotic resistance by microbes will result in increased mortality worldwide. There is a need to monitor and supervise infectious diseases in real-time.

Market Synopsis

Real-time surveillance and rapid growth in the IT-healthcare industry drive the software market’s expansion.

Software solutions are leading the product segment for infection surveillance solutions in the market. The major parameters that influence its growth are its ability to provide real-time surveillance of infectious diseases and the rampant growth of the IT-healthcare industry. Web-based solutions are gaining immense popularity owing to their availability in different configurations and immediate return on the initial investment. On-premise software solutions are feasible in hospitals owing to the low maintenance costs incurred and the low subscription fee. The services segment will grow at a steady pace during the forecast period owing to the entry of a large number of market participants willing to provide outsourcing solutions related to infection surveillance.

Prolonged use of catheters and an increasing number of patients with a suppressed immune system drive the urinary tract infection market’s growth.

Urinary tract infection is the leading type segment for the infection surveillance solutions market. The growing number of patients with a suppressed immune system and the prolonged use of catheters drive the growth of the urinary tract infection market. It is more common in the female population than in the male population. The “others” segment comprises infections caused by pneumonia-causing microbes and methicillin-resistant Staphylococcus aureus bacteria. They will register growth at a rapid pace on account of a significant rise in hospital-acquired infections worldwide.

An increasing number of inbound patients and a significant rise in the number of surgeries performed to drive the hospital market’s growth.

In the present scenario, hospitals are dominating the end-user segment of the market for infection surveillance solutions. The key factors that determine its outstanding growth are the increasing number of inbound patients and the rise in the number of surgeries performed. Long-term care centers will witness fast growth during the forecast period from 2018 to 2026, owing to their ability to combat antimicrobial resistance infections and increase outbound patient traffic due to the low healthcare costs incurred.

In North America, market growth is being driven by the rising prevalence of hospital-acquired infections (HAI) and the presence of an excellent healthcare framework.

Currently, North America holds a 35% share of the regional segment of the global infection surveillance solutions market. The important parameters that are responsible for the excellent market growth in North America are the existence of an excellent healthcare framework and the rising prevalence of hospital-acquired infections. The presence of pioneering IT-healthcare companies specializing in providing infection surveillance solutions, such as Truven Health Analytics, Becton Dickinson & Company, and Baxter International, Inc., etc. further consolidates the market growth in North America. Europe is the second-largest regional market, accounting for 30% of the share, owing to proactive government policy in fighting infectious disease and enhanced funding in the research and development segment to counteract the microbial resistance issue. Asia Pacific accounts for 20% of the market and is expected to grow steadily due to the presence of a large patient pool suffering from hospital-acquired infection and rising public health awareness about infectious diseases.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The infection surveillance solutions market segmentation is as follows:

IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, R.L. Solutions, Wolters Kluwer N.V.

Key questions are answered in this report.

• Which are the major IT-healthcare companies providing infection surveillance solutions?
• What is the global mortality rate for hospital-acquired infections and bacterial antibiotic resistance?
• What is the role of software solutions in monitoring infectious diseases?
• What is the disease etiology associated with a urinary tract infection?
• What is the healthcare burden incurred by hospitals related to infectious diseases?
• Why is North America the leading regional segment in the infection surveillance solutions market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global ISS Market Portraiture
2.2. Global ISS Market, by Product, 2017 (US$ Mn)
2.3. Global ISS Market, by Type, 2017 (US$ Mn)
2.4. Global ISS Market, by End-Use, 2017 (US$ Mn)
2.5. Global ISS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Infection Surveillance Solutions (ISS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global ISS Market, by Key Players, 2017

Chapter 4. Global Infection Surveillance Solutions (ISS) Market, by Product
4.1. Overview
4.2. Services
4.3. Software

Chapter 5. Global Infection Surveillance Solutions (ISS) Market, by Type
5.1. Urinary Tract Infection
5.2. Surgical Site Infection
5.3. Blood Stream Infection
5.4. Others

Chapter 6. Global Infection Surveillance Solutions (ISS) Market, by End-Use
6.1. Overview
6.2. Hospitals
6.3. Long Term Care Centers
6.4. Others

Chapter 7. Global Infection Surveillance Solutions (ISS) Market, by Geography
7.1. Overview
7.2. North America ISS Market Analysis, 2016 – 2026
7.2.1. North America ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.2.3. North America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.2.4. North America ISS Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe ISS Market Analysis, 2016 – 2026
7.3.1. Europe ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.3.2. Europe ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.3.4. Europe ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific ISS Market Analysis, 2016 – 2026
7.4.1. Asia Pacific ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America ISS Market Analysis, 2016 – 2026
7.5.1. Latin America ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.5.2. Latin America ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.5.4. Latin America ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa ISS Market Analysis, 2016 – 2026
7.6.1. MEA ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.6.2. MEA ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.6.4. MEA ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Atlas Medical Software
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Becton Dickinson and Company
8.3. Baxter International, Inc.
8.4. Deb Group Ltd.
8.5. Gojo Industries, Inc.
8.6. Hygreen, Inc.
8.7. Premier, Inc.
8.8. RL Solutions
8.9. Truven Health Analytics
8.10. Wolters Kluwer N.V.

List of Figures

FIG. 1 Infection Surveillance Solutions (ISS) Market: Research Methodology
FIG. 2 ISS Market Segmentation
FIG. 3 Global ISS Market, by Product, 2017 (US$ Mn)
FIG. 4 Global ISS Market, by Type, 2017 (US$ Mn)
FIG. 5 Global ISS Market, by End-Use, 2017 (US$ Mn)
FIG. 6 Global ISS Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: by Geography, 2017
FIG. 8 Competitive Analysis: Global ISS Market, by Key Players, 2017
FIG. 9 Global Services Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 10 Global Software Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 11 Global Urinary Tract Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 12 Global Surgical Site Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 13 Global Blood Stream Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 14 Global Other Infections Market for Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 15 Global Hospitals Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 16 Global Long Term Care Centers Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 17 Global Other End-Use Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 18 U.S. ISS Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada ISS Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. ISS Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany ISS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe ISS Market, 2016 – 2026 (US$ Mn)
FIG. 23 China ISS Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan ISS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific ISS Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil ISS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico ISS Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America ISS Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC ISS Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of MEA ISS Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Infection Surveillance Solutions (ISS) Market Portraiture
TABLE 2 Global ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global ISS Market , by End-Use, 2016 – 2026 (US$ Mn)
TABLE 5 Global ISS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 7 North America ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 9 North America ISS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Europe ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 13 Europe ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 26 Atlas Medical Software: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Baxter International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Deb Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Gojo Industries, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Hygreen, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Premier, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 RL Solutions: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Truven Health Analytics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Wolters Kluwer N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)